Roche COVID-19 response

On Wednesday 11th March the World Health Organization (WHO) declared a pandemic in response to the COVID-19 outbreak. This is a serious health situation and we extend our sympathies to people who have lost loved ones, to patients and healthcare professionals. We recognise that the public and private sectors across the globe need to work together to help effectively manage this developing situation.

The COVID-19 pandemic continues to evolve rapidly and we are doing everything we can to contribute. Our people are working day and night to increase wherever possible the supply of key tests and medicines, we are partnering with local authorities and organisations to support front line healthcare providers, and we are continuing to help make sure that patients - many of whom have very serious illnesses - receive the treatment and care they need.


我们对响应的贡献侧重于我们现有的优势和能力:

COVID-19 Testing

可靠,高质量的检测对于帮助医疗保健系统克服这种大流行至关重要。我们致力于为世界上最具挑战性的医疗保健紧急情况提供测试解决方案。我们的应急响应团队迅速努力开发诊断测试,以检测导致Covid-19疾病的病毒和可以支持抗体检测的测试。两者都被美国食品和药物管理局授予紧急使用授权。两者也可以在接受CE标志的市场中提供。我们继续探索更多的方式,我们可以在这种大流行中提供测试支持。我们现有的诊断投资组合对于关键护理也在Covid-19危机期间支持医院的患者管理方面发挥了重要作用。

Investigating treatment options

我们积极参与了解我们现有投资组合的潜力。Roche已经证实了对多种临床试验的启动,也是在世界各地举行的其他,独立的LED,临床试验中收集和编制数据,以及与其他公司和研究组织合作。bob综合坑人bob下载地址

Our people

Under exceptional conditions around the world, colleagues at Roche are doing everything they can to ensure that patients – many of whom have very serious illnesses – receive the treatment and care they need and that we keep a complex value chain of diagnostics and medicines going and ensure continuity of care for other conditions.

While we respond to COVID-19, we also continue to deliver medicines and diagnostics wherever possible for patients across a broad range of other disease areas under exceptional conditions.

Public and private sectors across the globe must work together to address this challenge.

In these exceptional times, Roche stands shoulder to shoulder with governments, healthcare providers and all those working to overcome the pandemic.

The most important thing is our individual contribution to help flatten the curve by minimising the risk of infection. This is crucial, as it relieves the healthcare systems and helps patients around the world.”

Severin SchwanCEO of the Roche Group

标签:Society